Oct 16, 2014
A Prostate Cancer Learning Hub has been launched on website for healthcare professionals (HCPs), epgonline.org.
Oct 15, 2014
Patients with Chronic Obstructive Pulmonary Disease (COPD) will rank as the fifth leading cause of disability in 2030, accounting for almost 4% of total disability-adjusted life years (DALYs) lost worldwide. Many patients with COPD report that the...
Oct 14, 2014
Almost 3 million deaths a year are attributed to obesity, making it the fifth highest risk factor for death globally.
Oct 06, 2014
Asthma is a chronic inflammatory disorder of the airways affecting over 300 million people globally, with symptoms that cause 15 million disability-adjusted life-years (DALYs) to be lost each year. Identifying and tackling the specific symptoms of..
May 01, 2014
Over the last three decades the prevalence of Type 2 Diabetes Mellitus has increased from 30 million in 1985 to 366 million in 2011 and this figure is expected to reach a staggering 552 million by 2030.1 In Europe the current number of people with...
Feb 03, 2014
Nocturnal enuresis (bedwetting) is a common condition affecting approximately 16% of 5 year old children. It can have a profound impact on them and their families, often affecting self-esteem, relationships, sleep quality and academic development.
Dec 17, 2012
EPG Health Media (Europe) Ltd has released a follow-up to its 2010 comparative study of doctors use smartphones and tablet PCs in Europe and the US.
Dec 11, 2012
EPG Online has launched the Heart Failure Knowledge Centre - a free online educational resource for physicians within www.epgonline.org
Nov 26, 2012
EPG Health Media have released results from market research conducted in October 2012. The report observes the responses of 180 European HCPs to a survey about their behaviour, views and requirements concerning traditional and online forms of CME.
Nov 15, 2012
EPG Health Media has announced the launch of it’s latest interactive educational resource for healthcare professionals - the Prostate Cancer Knowledge Centre.